ycliper

Популярное

Музыка Кино и Анимация Автомобили Животные Спорт Путешествия Игры Юмор

Интересные видео

2025 Сериалы Трейлеры Новости Как сделать Видеоуроки Diy своими руками

Топ запросов

смотреть а4 schoolboy runaway турецкий сериал смотреть мультфильмы эдисон
Скачать

The CEO Just Sold, Should You As Well? (HIMS Stock Analysis)

Автор: How to Invest

Загружено: 2025-08-20

Просмотров: 3374

Описание: Hims & Hers might be one of the most overlooked growth stocks in healthcare. In this video, I break down their latest earnings, AI doctor initiatives, new longevity medicine plans, and why I’m personally so bullish on HIMS stock. We’ll cover the bull and bear cases, long-term growth projections, and what makes this company uniquely positioned to disrupt traditional healthcare.

Do you think Hims & Hers could become a healthcare giant? Let me know in the comments — and if you find this breakdown helpful, don’t forget to like and subscribe for more stock deep dives.

Sources used in this video:
MarketWatch – Hims & Hers CEO sells $33 million in stock
https://www.marketwatch.com/story/him...
Hims & Hers Health Inc. – Q2 2025 Financial Results
https://investors.hims.com/news/news-...

🎉 Join our brand-new Discord community — it’s free!
We’re building a fun, supportive space for like-minded investors to share their favorite stocks, ask questions, and help shape future video topics. Whether you're just getting started or deep into the markets, we’d love to have you.
👉   / discord  

Curious about how to invest? You’re in the right place. Whether you're just starting out or you're an experienced investor looking for in-depth stock market analysis and interviews — this channel is for you.

My mission is to provide extreme value through high-quality investing videos that are easy to understand yet rooted in proven, long-term strategies taught by legends like Peter Lynch and Warren Buffett. Every video is designed to help you invest smarter and build wealth with clarity and confidence.

👤 About Me:
I'm Jake — a lifelong learner, investor, and creator. I’m passionate about helping others make informed decisions and thrive in both traditional investing and the future of finance.

🔗 Connect with Me:
X (Twitter): https://x.com/HowToInvest_jb
Instagram:   / howtoinvest_jb  
TikTok: https://www.tiktok.com/@howtoinvest_j...
Facebook: https://www.facebook.com/profile.php?...
🎥 My ""Top 10"" Channel: [   / @jakebrowatzke  ](   / @jakebrowatzke  )

⚠️Disclaimer:
All videos on this channel are for educational and entertainment purposes only. I’m not a financial advisor, and nothing here is investment advice. While I strive to provide accurate and timely information, always do your own research before making any financial decisions. Your money, your responsibility. Invest smart — and stay safe out there!

Не удается загрузить Youtube-плеер. Проверьте блокировку Youtube в вашей сети.
Повторяем попытку...
The CEO Just Sold, Should You As Well? (HIMS Stock Analysis)

Поделиться в:

Доступные форматы для скачивания:

Скачать видео

  • Информация по загрузке:

Скачать аудио

Похожие видео

Смогут ли HIMS действительно достичь $82,07? Вот что им нужно сделать!

Смогут ли HIMS действительно достичь $82,07? Вот что им нужно сделать!

Stock Explodes After Earnings: Still a Buy? (Lemonade Stock Analysis)

Stock Explodes After Earnings: Still a Buy? (Lemonade Stock Analysis)

Where Will Hims & Hers Stock Be in 2030? | HIMS Stock Analysis | HIMS Stock Prediction

Where Will Hims & Hers Stock Be in 2030? | HIMS Stock Analysis | HIMS Stock Prediction

Ep 39 - Legendary Wall St. analyst David Maris on why Hims could be massive—and what could go wrong

Ep 39 - Legendary Wall St. analyst David Maris on why Hims could be massive—and what could go wrong

Ep 32 - Antonio Linares Makes the Case for Hims as a 100x — From Here

Ep 32 - Antonio Linares Makes the Case for Hims as a 100x — From Here

Акции Hims & Hers по-прежнему имеют коэффициент 10x?

Акции Hims & Hers по-прежнему имеют коэффициент 10x?

Neoclouds: подробный анализ IREN и NEBIUS!

Neoclouds: подробный анализ IREN и NEBIUS!

Invest in This – It’ll Be Worth $1.5 Million by 2030 | World Leading Investing Expert

Invest in This – It’ll Be Worth $1.5 Million by 2030 | World Leading Investing Expert

Анализ управления UiPath: Можно ли доверять генеральному директору?

Анализ управления UiPath: Можно ли доверять генеральному директору?

Компания UiPath превзошла все ожидания в 3 квартале 2026 года! (Краткий обзор результатов телефон...

Компания UiPath превзошла все ожидания в 3 квартале 2026 года! (Краткий обзор результатов телефон...

AMD's CEO Wants to Chip Away at Nvidia's Lead | The Circuit with Emily Chang

AMD's CEO Wants to Chip Away at Nvidia's Lead | The Circuit with Emily Chang

Ep 30 - Mark Cuban on Cost Plus Drugs, Hims & Hers, and the Future of Healthcare

Ep 30 - Mark Cuban on Cost Plus Drugs, Hims & Hers, and the Future of Healthcare

Моё «несправедливое преимущество» на фондовом рынке

Моё «несправедливое преимущество» на фондовом рынке

Mohnish Pabrai: FASTEST Way To Financial Freedom! Proven Playbook For Quitting Your 9-5 In 9 Months!

Mohnish Pabrai: FASTEST Way To Financial Freedom! Proven Playbook For Quitting Your 9-5 In 9 Months!

Ep 23 - Andrew Dudum: Founder & CEO of Hims & Hers

Ep 23 - Andrew Dudum: Founder & CEO of Hims & Hers

Фондовый рынок для начинающих 2025/26 – Полное руководство по инвестициям.

Фондовый рынок для начинающих 2025/26 – Полное руководство по инвестициям.

Почему рынок ошибается в отношении UiPath (RPA не умерла)

Почему рынок ошибается в отношении UiPath (RPA не умерла)

HIMS Stock Is About To Explode! ( Here's Why)

HIMS Stock Is About To Explode! ( Here's Why)

Should Investors Buy Oscar Health Stock? | OSCR Stock Analysis | Best Healthcare Stocks to Buy

Should Investors Buy Oscar Health Stock? | OSCR Stock Analysis | Best Healthcare Stocks to Buy

Is This AI Stock Disrupting a $400B Industry?

Is This AI Stock Disrupting a $400B Industry?

© 2025 ycliper. Все права защищены.



  • Контакты
  • О нас
  • Политика конфиденциальности



Контакты для правообладателей: [email protected]